openPR Logo
Press release

Global Lung Cancer Surgery Market Size, Share, and Forecast Analysis 2025-2029

08-25-2025 09:51 AM CET | Health & Medicine

Press release from: The Business Research Company

Lung Cancer Surgery Market Size

Lung Cancer Surgery Market Size

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

What Are the Lung Cancer Surgery Market Size Forecast for 2025?
Significant growth has been observed in recent years in the lung cancer surgery market size. The market is predicted to expand from $5.07 billion in 2024 to $5.33 billion in 2025, revealing a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this growth during the historic period include a high prevalence of smoking, increasing incidents of lung cancer, development in hospital infrastructure, expansion in insurance coverage, and enhancement in surgeon expertise.

What Is the Market Size Outlook for Lung Cancer Surgery Until 2029?
Stable expansion is anticipated in the lung cancer surgery market size in the upcoming years. It is set to rise to $6.43 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.8%. This projected growth over the forecast period can be linked to factors such as the growing elderly population worldwide, an increase in non-small cell lung cancer instances, enhanced awareness in developing nations, a rise in the use of robotic surgical platforms, and amplified investments in cancer care. The forthcoming period will witness trends such as robotic-assisted thoracic surgery, augmented reality application in surgeries, the use of 3D printing for surgical simulation, artificial intelligence in surgical planning, and intelligent surgical tools.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

What Are the Major Factors Driving Demand in the Lung Cancer Surgery Market?
The lung cancer surgery market is anticipated to expand due to the rising occurrence of lung cancer. This type of cancer, typified by irregular cell growth in one or both lungs, affects normal lung functionality. The pollution in the air and prime particulate matter to which people are exposed over long periods is augmenting the risk of lung cancer, given that these micro-particles can infiltrate the lungs in depth and cause inflammation, cell deterioration, and mutation, potentially leading to cancer. Lung cancer surgeries enable us to curb the death toll related to lung cancer by facilitating the early excision of malignant tumors before they proliferate or advance. The Centers for Disease Control and Prevention, a government agency in the US, cited in June 2025 that lung cancer was the cause of 131,584 deaths in the country in 2023, after 218,893 cases were reported new in 2022. Consequently, the escalating prevalence of lung cancer is driving the growth of the lung cancer surgery market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

How Are End-Use Segments Shaping the Lung Cancer Surgery Market Outlook?
The lung cancer surgery market covered in this report is segmented -

1) By Type: Minimally Invasive Surgeries
2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction
3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments
4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels
5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:
1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection
2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Are the Strategic Trends Transforming the Lung Cancer Surgery Market Landscape?
Significant players in the lung cancer surgery market, such as Johnson & Johnson MedTech, are concentrating on the creation of advanced technology like robotic-assisted surgeries. These technologies enhance the accuracy of surgeries, minimise recovery time and boost patient results. Robotic-assisted surgical methods refer to those procedures which utilize robotic systems, controlled by surgeons, to augment precision, lessen complications, and better patient recovery outcomes. A prime illustration being in March 2025, when Johnson & Johnson MedTech, reportedly received approval for MONARCH QUEST from under U.S. 510(k). This robotic-assisted bronchoscopy technology offers superior reach and stability for accessing tiny lung nodules which are typically hard to reach, thereby augmenting the ability to detect lung cancer at a premature stage. It provides improved maneuverability and blends seamlessly with imaging technologies for accurate biopsies, causing minimal discomfort to the patients. MONARCH QUEST is designed to broaden the scope of procedures and improve workflow efficiency. It lends greater clinical confidence and consistency across an extensive array of bronchoscopic procedures.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

Who Are the Prominent Companies in the Lung Cancer Surgery Market by ?
Major companies operating in the lung cancer surgery market are Johnson & Johnson, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, Varian Medical Systems Inc., Karl Storz SE, Lepu Medical Technology (Beijing) Co. Ltd., Ambu A/S, Accuray Incorporated, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc., AngioDynamics Inc., Ackermann Instrument GmbH, Scanlan International Inc., Sontec Instruments Inc., Covidien LLC

Which Region Is Expected to See the Highest CAGR in the Lung Cancer Surgery Market?
North America was the largest region in the lung cancer surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Lung Cancer Surgery Market Size, Share, and Forecast Analysis 2025-2029 here

News-ID: 4157528 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Surgery

Dental Surgery Conference | Dental Surgery Congress | Chicago | USA
Dental Surgery 2024We are delighted to invite dental professionals from all over the world to join us for an exceptional and comprehensive dental conference the 40th International Conference on Dental Surgery and Medicine. This event is designed to facilitate knowledge sharing, networking, and exploration of the latest advancements in the field of dentistry. Theme: "A better life starts with a beautiful smile" Date: June 06-07, 2024 Venue: Chicago,USA Chicago,USA CHICAGO Dental Surgery 2024We are delighted to
Intraoperative Neuromonitoring Market Size to Hit Valuation of $4.90 Billion by …
IONM would improve intraoperative decision-making, by guiding a surgeons hands during surgery to reduce potential neurological risk. This benefits patients with a better surgical outcome and reduces a surgeons liability to a great extent. Global Intraoperative Neuromonitoring (IONM) Market was valued at $3,036 million in 2015, and is projected to reach $4,900 million by 2022, growing at a CAGR of 7% from 2016 to 2022, according to a new report published
Hemostats Market Research Insights by Major Applications Survey on cardiovascula …
Hemostasis is the course of blood clotting. Blood clotting plays a vital role in various surgeries by achieving positive outcomes with the reduction of blood loss. This clotting process reduces the surgery time and the need for blood transfusion. Thus, hemostats are surgical instruments used to regulate the bleeding during surgery. Hemostats are also used for oozing out venomous bleeds, bone bleeding, and others. The scope of hemostats is growing rapidly
Europe Data for Surgeries by Surgery Type (Hip Implant, Major Peritoneal Surgery …
The number of hip implant surgeries, major peritoneal surgeries, thoracic surgeries, and ENT surgeries along with the surgeries for central nervous system (CNS), in Europe were valued at 35,860 thousand procedures in 2016 and is projected to reach 41,818 thousand procedures by 2023. The study includes number of hip implants and major peritoneal, thoracic, CNS, and ENT surgeries performed in Europe. In addition, the report includes other relevant details for
Surgical Robotics Market Growth Study by Component [Systems, Accessories and Ser …
Robotic surgery is a type of minimally invasive surgery which utilizes robotics for performing surgical procedures. These robotic systems are operated by surgeons and consists of miniaturized surgical instruments which are mounted on robotic arms, thus allowing surgeons to perform the surgeries precisely. The global surgical robotics market was valued at $56,294.9 million in 2017, and is expected to reach $98,737.0 million by 2024 at a CAGR of 8.5% during
Surgical Robotics Market Report 2018: Segmentation by Component (Systems, Access …
Global Surgical Robotics market research report provides company profile for Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Intuitive Surgical, Inc., KUKA AG, Stryker Corporation (MAKO Surgical Corp.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth